IL-33 anticorps
Aperçu rapide pour IL-33 anticorps (ABIN296328)
Antigène
Voir toutes IL-33 (IL33) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Selected for its ability to recognize human IL-33 in direct ELISAs and Western Blots.
-
Purification
- Affinity purified
-
Immunogène
- E. coli-derived rhIL-33.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA, ICC, WB
Usage: Immunocytochemistry: 5-15 μg/mL using immersion fixed human PBMCs treated with PMA and calcium ionomycinNeutralization: Measured by its ability to neutralize IL33induced proliferation in the D10.G4.1 mouse helper T cell line. The Neutralization Dose (ND50) is typically 0.753.0 μg/mL in the presence of 1 ng/mL recombinant human IL33 and suboptimal amounts of mouse CD3-epsilon monoclonal antibody.Western Blot: 0.1 μg/mL using rhIL-33 as sample -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- deionized water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized.
-
-
- IL-33 (IL33) (Interleukin 33 (IL33))
-
Autre désignation
- IL33
-
Sujet
-
Name/Gene ID: IL33
Family: Interleukin
Synonyms: IL33, C9orf26, DVS27, DVS27-related protein, IL-1F11, IL-33, Interleukin-33, NFEHEV, NF-HEV, Interleukin-1 family member 11, NFHEV, IL1F11, Interleukin 33, RP11-575C20.2 -
ID gène
- 90865
-
UniProt
- O95760
-
Pathways
- Production of Molecular Mediator of Immune Response
Antigène
-